Study of Intratumoral Hypoxia Using Pre-operative Administration of Pimonidazole
Status:
Completed
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
This study involves the administration of a hypoxia marker, pimonidazole hydrochloride, taken
orally approximately 24 hours before surgical resection of a pancreatic tumor in order to
identify areas of lower oxygen content on tumor samples.